Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec 6;14(12):1682-1683.
doi: 10.2215/CJN.12111019. Epub 2019 Nov 6.

Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies

Fadi Fakhouri  1 , Véronique Frémeaux-Bacchi  2
Affiliations
Editorial

Monitoring Complement Activation: The New Conundrum in Thrombotic Microangiopathies

Fadi Fakhouri et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: alternative complement pathway; atypical hemolytic uremic syndrome; complement; complement activation; eculizumab; hemolytic uremic syndrome; humanized monoclonal antibodies; nephrologists; risk factors; thrombotic microangiopathies; thrombotic microangiopathy.

PubMed Disclaimer

Comment on

  • Complement Activation and Thrombotic Microangiopathies.
    Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M. Palomo M, et al. Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1719-1732. doi: 10.2215/CJN.05830519. Epub 2019 Nov 6. Clin J Am Soc Nephrol. 2019. PMID: 31694864 Free PMC article.

References

    1. Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar E, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M: Complement activation and thrombotic microangiopathies. Clin J Am Soc Nephrol 14: 1719–1732, 2019 - PMC - PubMed
    1. Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C: Haemolytic uraemic syndrome. Lancet 390: 681–696, 2017 - PubMed
    1. Bu F, Meyer NC, Zhang Y, Borsa NG, Thomas C, Nester C, Smith RJ: Soluble c5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome. Am J Kidney Dis 65: 968–969, 2015 - PubMed
    1. Gavriilaki E, Yuan X, Ye Z, Ambinder AJ, Shanbhag SP, Streiff MB, Kickler TS, Moliterno AR, Sperati CJ, Brodsky RA: Modified Ham test for atypical hemolytic uremic syndrome. Blood 125: 3637–3646, 2015 - PMC - PubMed
    1. Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G: Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 124: 1715–1726, 2014 - PMC - PubMed